Alpha 2.0
Login Register
» Authors » L Arcaini

L Arcaini

Explore the profile of L Arcaini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 1015
Followers 0
Related Specialties
Oncology
Reproductive Medicine
Gynecology & Obstetrics
Top 10 Co-Authors
L Fedele
S Bianchi
M Lazzarino
P Vercellini
G B CANDIANI
F Passamonti
C Pascutto
M Merli
E Orlandi
M Paulli
Published In
Ann Oncol
Fertil Steril
Eur J Obstet Gynecol Reprod Biol
Haematologica
Leukemia
Affiliations
Soon will be listed here.
Recent Articles
1.
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma
Pinto A, Caltagirone M, Battista M, Gazzoli G, Patti C, Pennese E, et al.
Br J Haematol . 2024 Jul; 205(6):2219-2227. PMID: 39039666
URBAN is a multicentric, ambispective study evaluating the effectiveness and safety of obinutuzumab-based immuno-chemotherapy and maintenance in patients with untreated advanced follicular lymphoma (FL). The study began before the COVID-19...
2.
Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29]
Zucca E, Arcaini L, Buske C, Johnson P, Ponzoni M, Raderer M, et al.
Ann Oncol . 2022 Dec; 34(3):325. PMID: 36529567
No abstract available.
3.
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
Buske C, Dreyling M, Alvarez-Larran A, Apperley J, Arcaini L, Besson C, et al.
ESMO Open . 2022 Mar; 7(2):100403. PMID: 35272130
Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. Methods: This...
4.
Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients
Zappasodi P, Brociner M, Merati G, Nizzoli M, Roncoroni E, Boveri E, et al.
Ann Hematol . 2020 Nov; 100(4):1111-1113. PMID: 33175198
No abstract available.
5.
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Zucca E, Arcaini L, Buske C, Johnson P, Ponzoni M, Raderer M, et al.
Ann Oncol . 2020 Jan; 31(1):17-29. PMID: 31912792
No abstract available.
6.
From hepatitis C virus infection to B-cell lymphoma
Couronne L, Bachy E, Roulland S, Nadel B, Davi F, Armand M, et al.
Ann Oncol . 2017 Oct; 29(1):92-100. PMID: 29045541
In addition to liver disorders, hepatitis C virus (HCV) is also associated with extrahepatic immune manifestations and B-cell non-Hodgkin lymphoma (NHL), especially marginal zone lymphoma, de novo or transformed diffuse...
7.
The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis
Peveling-Oberhag J, Arcaini L, Bankov K, Zeuzem S, Herrmann E
J Viral Hepat . 2016 Mar; 23(7):536-44. PMID: 26924533
Many epidemiological studies provide solid evidence for an association of chronic hepatitis C virus (HCV) infection with B-cell non-Hodgkin's lymphoma (B-NHL). However, the most convincing evidence for a causal relationship...
8.
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma
Piva R, Deaglio S, Fama R, Buonincontri R, Scarfo I, Bruscaggin A, et al.
Leukemia . 2014 Oct; 29(2):503-7. PMID: 25283840
No abstract available.
9.
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi
Arcaini L, Vallisa D, Rattotti S, Ferretti V, Ferreri A, Bernuzzi P, et al.
Ann Oncol . 2014 May; 25(7):1404-1410. PMID: 24799461
Background: Tumor regression after antiviral therapy (AT) is in favor of an etiological role of hepatitis C virus (HCV) in non-Hodgkin's B-cell lymphomas (NHL). Patients And Methods: We carried out...
10.
Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network
Cheah C, George A, Gine E, Chiappella A, Kluin-Nelemans H, Jurczak W, et al.
Ann Oncol . 2013 Apr; 24(8):2119-23. PMID: 23616279
Background: Central nervous system (CNS) involvement in mantle cell lymphoma (MCL) is uncommon, and the manifestations and natural history are not well described. Patients And Methods: We present the data...